Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tennvall

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Induction chemotherapy (cisplatin + 5-fluorouracil) and radiotherapy in advanced squamous cell carcinoma of the head and neckJ Tennvall, M Albertsson, A Biörklund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997
Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibodyM Garkavij, J Tennvall, S E Strand, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Thyroid tissue characterization by proton magnetic resonance relaxation time determinationJ Tennvall, M Olsson, T Möller, et al.
Cancer Research|December 1, 1995
Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in ratsM Garkavij, J Tennvall, S E Strand, et al.
Acta Oncologica (Stockholm, Sweden)|August 16, 2001
Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomasE Brun, U Zätterström, E Kjellén, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Improving radioimmonotargeting of tumors. Variation in the amount of L6 MAb administered, combined with an immunoadsorption system (ECIA)M Garkavij, J Tennvall, S E Strand, et al.
Scandinavian Journal of Urology and Nephrology|August 29, 2000
Palliative radiation with a radiolabeled diphosphonate (rhenium-186 etidronate) in patients with hormone-refractory disseminated prostate carcinomaJ Tennvall, P A Abrahamsson, G Ahlgren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Comparison of 125I- and (111)In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorptionM Garkavij, J Tennvall, T Ohlsson, et al.
Cancer|February 1, 1994
A general extracorporeal immunoadsorption method to increase tumor-to-tissue ratioS E Strand, K Norrgren, M Garkavij, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 10, 2011
Dosimetry in patients with B-cell lymphoma treated with [(90)Y]ibritumomab tiuxetan or [(131)I]tositumomabK Sjögreen-Gleisner, Y K Dewaraja, C Chiesa, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Induction chemotherapy (cisplatin + 5-fluorouracil) and radiotherapy in advanced squamous cell carcinoma of the head and neckJ Tennvall, M Albertsson, A Biörklund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997
Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibodyM Garkavij, J Tennvall, S E Strand, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Thyroid tissue characterization by proton magnetic resonance relaxation time determinationJ Tennvall, M Olsson, T Möller, et al.
Cancer Research|December 1, 1995
Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in ratsM Garkavij, J Tennvall, S E Strand, et al.
Acta Oncologica (Stockholm, Sweden)|August 16, 2001
Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomasE Brun, U Zätterström, E Kjellén, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Improving radioimmonotargeting of tumors. Variation in the amount of L6 MAb administered, combined with an immunoadsorption system (ECIA)M Garkavij, J Tennvall, S E Strand, et al.
Scandinavian Journal of Urology and Nephrology|August 29, 2000
Palliative radiation with a radiolabeled diphosphonate (rhenium-186 etidronate) in patients with hormone-refractory disseminated prostate carcinomaJ Tennvall, P A Abrahamsson, G Ahlgren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Comparison of 125I- and (111)In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorptionM Garkavij, J Tennvall, T Ohlsson, et al.
Cancer|February 1, 1994
A general extracorporeal immunoadsorption method to increase tumor-to-tissue ratioS E Strand, K Norrgren, M Garkavij, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 10, 2011
Dosimetry in patients with B-cell lymphoma treated with [(90)Y]ibritumomab tiuxetan or [(131)I]tositumomabK Sjögreen-Gleisner, Y K Dewaraja, C Chiesa, et al.
Pageof 7